Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Health Information Framing, Source Characteristics, and Health Behavior Promotion

sunnuntai 8. marraskuuta 2026 päivittänyt: Jing Guo, Peking University

Research on Health Information Framework, Information Sources and Promotion of Health Behaviors

This study examines how different ways of presenting health information affect health-related understanding, decision-making, and behavior. It includes two connected research components: one focuses on vaccination-related decisions, and the other focuses on mental health and help-seeking. Participants will complete an online questionnaire and will be randomly assigned to different information conditions that vary in message framing, information source, social norms, and presentation format. The study will compare post-exposure decision intentions and behavioral responses across the assigned conditions. No medicines, vaccines, or medical devices will be administered as part of the study.

Tutkimuksen yleiskatsaus

Tila

Ei vielä rekrytointia

Ehdot

Yksityiskohtainen kuvaus

Health information can influence how people understand health risks, evaluate available options, and make health-related decisions. This prospective behavioral study will use an online questionnaire and a randomized parallel-group design to evaluate how different characteristics of health information affect health-related decision intention and behavioral responses.

The study consists of two connected components conducted in different participant populations and regions. The first component examines how the source and framing of vaccination-related information influence participants' evaluation, decision intention, trust, and subsequent behavioral choices. The second component examines how differently framed mental health information, source cues, and social norms influence mental health-related decision-making and help-seeking responses.

In each component, eligible participants will provide informed consent and will be randomly assigned through an online survey platform to one of several pre-specified information conditions or a comparison condition. Outcomes will be assessed through self-reported questionnaire measures and behavioral responses recorded by the survey platform, including the decision to view further information or proceed with an available follow-up action.

The study does not administer or evaluate the safety or efficacy of any drug, biological product, vaccine, or medical device. All study procedures will be conducted using a secure online platform in accordance with the approved study protocol and applicable ethical requirements.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

102000

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

Opiskelupaikat

    • Beijing Municipality
      • Beijing, Beijing Municipality, Kiina, 101118
        • Beijing Tongzhou Psychiatric Hospital
        • Ottaa yhteyttä:
    • Hunan
      • Changsha, Hunan, Kiina
        • The Third Xiangya Hospital of Central South University
        • Ottaa yhteyttä:
          • Xiuhong Yuan, PhD
          • Puhelinnumero: 86+15308488051
          • Sähköposti: 18483195@qq.com

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

10 vuotta ja vanhemmat (Lapsi, Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Joo

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Aged 10 years or older.
  • Component 1: Young adults entering higher education who meet the age and enrollment requirements specified in the approved protocol.
  • Component 2: Adolescents and their primary caregivers who meet the age, grade, recruitment-site, and paired-participation requirements specified in the approved protocol.
  • Able to understand the study information and complete the online questionnaire with any assistance permitted by the approved protocol.
  • Voluntarily participates and provides electronic informed consent. For minors, guardian consent and participant assent are obtained as required.

Exclusion Criteria:

  • Unable to provide informed consent or, where applicable, guardian consent and participant assent.
  • Does not meet the eligibility requirements for either study component.
  • Component 1: Has already completed the relevant full vaccination schedule, where specified as an exclusion criterion in the approved protocol.
  • Questionnaire response is invalid because of severe missingness, an implausible completion time, failed quality-control items, or clear logical inconsistency.
  • Any additional component-specific exclusion criterion specified in the approved protocol.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Terveyspalvelututkimus
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Ei mitään (avoin tarra)

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Ei väliintuloa: No-information control (Component 1)
Kokeellinen: AI-sourced gain-framed message (Component 1)

Participants view an AI-sourced message emphasizing the benefits of vaccination.

Kokeellinen: AI-sourced loss-framed message (Component 1)

Participants view an AI-sourced message emphasizing the risks of not being vaccinated.

Kokeellinen: AI-sourced normative message (Component 1)

Participants view an AI-sourced message emphasizing social or public-health approval of vaccination.

Kokeellinen: AI-sourced structured message (Component 1)

Participants view an AI-sourced message explaining vaccination and booking procedures in a structured format.

Kokeellinen: AI-sourced expert-authority message (Component 1)

Participants view an AI-sourced message attributed to professional or expert authority.

Kokeellinen: Official gain-framed message (Component 1)

Participants view an official message emphasizing the benefits of vaccination.

Kokeellinen: Official loss-framed message (Component 1)

Participants view an official message emphasizing the risks of not being vaccinated.

Kokeellinen: Official normative message (Component 1)

Participants view an official message emphasizing social or public-health approval of vaccination.

Kokeellinen: Official structured message (Component 1)

Participants view an official message explaining vaccination and booking procedures in a structured format.

Kokeellinen: Official expert-authority message (Component 1)

Participants view an official message attributed to professional or expert authority.

Kokeellinen: Gain-framed peer message (Component 2)

Participants view a gain-framed message emphasizing the benefits of mental health help-seeking, with peer social cues.

Kokeellinen: Gain-framed expert message (Component 2)

Participants view a gain-framed message emphasizing the benefits of mental health help-seeking, attributed to an expert source.

Kokeellinen: Loss-framed peer message (Component 2)

Participants view a loss-framed message emphasizing the risks of not seeking mental health support, with peer social cues.

Kokeellinen: Loss-framed expert message (Component 2)

Participants view a loss-framed message emphasizing the risks of not seeking mental health support, attributed to an expert source.

Kokeellinen: Social-norm message (Component 2)

Participants view a message presenting help-seeking as a common and socially approved behavior.

Ei väliintuloa: Blank-reminder control (Component 2)

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
HPV vaccination intention
Aikaikkuna: Immediately after exposure to the assigned health information condition (post-exposure questionnaire).

In the Hunan population, assessed immediately after exposure with one 5-point item: "I am willing to receive the HPV vaccine in the future." Responses range from

1 (strongly disagree) to 5 (strongly agree). Higher scores indicate stronger intention to receive the HPV vaccine.

Immediately after exposure to the assigned health information condition (post-exposure questionnaire).
Professional mental health help-seeking intention
Aikaikkuna: Immediately after exposure to the assigned health information condition (post-exposure questionnaire).

In Tongzhou students and primary caregivers, assessed using three 7-point items asking how likely the participant would be to seek help from a psychologist, a psychiatrist, and another doctor if experiencing persistent emotional distress or thoughts of self-harm. Scores range from 1 (definitely would not) to 7 (definitely would). The mean of the three items will be calculated; higher scores indicate stronger professional help-seeking intention.

Immediately after exposure to the assigned health information condition (post-exposure questionnaire).
HPV vaccination booking-directed action
Aikaikkuna: During the same online session immediately after exposure to the assigned health information condition.

In the Hunan population, a binary behavioral outcome recorded by the online questionnaire platform after exposure. A positive response is defined as either selecting direct booking at the first decision point or agreeing to provide contact information for HPV vaccination booking at the end of the booking pathway. Viewing information without proceeding to booking or providing contact information is not counted as a positive response.

During the same online session immediately after exposure to the assigned health information condition.

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
HPV vaccine trust
Aikaikkuna: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed with five HPV-adapted Vaccine Trust Gauge items covering vaccine safety, protection against serious illness, relative health risk, benefits versus risks, and effectiveness. Responses will be scored in the direction of greater trust using the prespecified VTG scoring and missing response rules. The item mean will be rescaled to 0-100; higher scores indicate greater trust.

Immediately after exposure to the assigned health information condition.
Trust in HPV vaccine information sources
Aikaikkuna: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed with five Vaccine Trust Gauge-adapted items measuring trust in HPV vaccine recommendations from schools or official institutions, doctors or nurses, family or friends, classmates or peers, and social media. Responses will be scored using the same prespecified VTG rules. The item mean will be rescaled to 0-100; higher scores indicate greater trust.

Immediately after exposure to the assigned health information condition.
HPV vaccination readiness (7C-based)
Aikaikkuna: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed using seven HPV-adapted 7C vaccination- readiness items covering calculation, collective responsibility, confidence in the system, confidence in vaccine safety, social conformity, convenience or constraints, and complacency. Items will be reverse scored where required and averaged so that higher scores indicate greater vaccination readiness.

Immediately after exposure to the assigned health information condition.
Perceived susceptibility to HPV infection
Aikaikkuna: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed using the mean of three 5-point Health Belief Model items representing perceived susceptibility to HPV infection. Items will be reverse scored as specified in the analysis plan so that higher scores indicate greater perceived susceptibility.

Immediately after exposure to the assigned health information condition.
Perceived severity of HPV infection
Aikaikkuna: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed using one reverse-scored 5-point Health Belief Model item concerning whether the health effects of HPV infection are not serious. The score will be transformed so that higher scores indicate greater perceived severity.

Immediately after exposure to the assigned health information condition.
Perceived barriers to HPV vaccination
Aikaikkuna: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed using the mean of six 5-point Health Belief Model items concerning perceived drawbacks, cost, insufficient information, uncertain long-term side effects, sexual stigma, and sensitivity of the topic. Higher scores indicate greater perceived barriers to HPV vaccination.

Immediately after exposure to the assigned health information condition.
Cues to action for HPV vaccination
Aikaikkuna: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed using the mean of two 5-point Health Belief Model items concerning exposure to media reports promoting HPV vaccination and the influence of a doctor's recommendation. Higher scores indicate stronger cues to action.

Immediately after exposure to the assigned health information condition.
Help-seeking efficacy attitudes related to mental health
Aikaikkuna: Immediately after exposure to the assigned school-based health message.

In Tongzhou students and primary caregivers, assessed using the Help-Seeking dimension of the Universal Mental Health Literacy Scale for Adolescents (UMHL-A). Five applicable items are used in students and four in caregivers. Items are scored on a 5-point scale, averaged, and rescaled to 0-100. Higher scores indicate more favorable help-seeking attitudes.

Immediately after exposure to the assigned school-based health message.
Stigma-related attitudes toward mental health
Aikaikkuna: Immediately after exposure to the assigned school-based health message.

In Tongzhou students and primary caregivers, assessed using the three-item Stigma dimension of the Universal Mental Health Literacy Scale for Adolescents (UMHL-A). Items are scored on a 5-point scale, averaged, and rescaled to 0-100 in the direction of less stigmatizing and more favorable attitudes.

Immediately after exposure to the assigned school-based health message.
Intention to use generative AI for HPV vaccination information
Aikaikkuna: Immediately after exposure to the assigned health information condition.

In the Hunan population, assessed using two post-exposure 5-point items asking whether the participant is willing to use an AI chatbot to obtain further HPV vaccination information and whether generative AI would be used as one source of HPV vaccination information. Both items will be coded in the direction of greater intention and averaged.

Immediately after exposure to the assigned health information condition.
Benevolence dimension of trust in generative AI for health information
Aikaikkuna: Immediately after exposure to the assigned health information condition.

In Hunan and Tongzhou participants, assessed using the three-item Benevolence dimension of the Human-Generative AI Trust Scale, adapted to HPV vaccination or mental health information. The items assess whether generative AI acts in the participant's best interest, is willing to understand the participant's needs and preferences, and will help to the best of its ability. Items use a 5-point response scale and are averaged; higher scores indicate greater benevolence-based trust.

Immediately after exposure to the assigned health information condition.
Competence dimension of trust in generative AI for health information
Aikaikkuna: Immediately after exposure to the assigned health information condition.

In Hunan and Tongzhou participants, assessed using the three-item Competence dimension of the Human-Generative AI Trust Scale. The items assess whether generative AI can effectively support the participant in understanding health information, performs well in providing health information support, and has the expected functions for that role. Items use a 5-point response scale and are averaged; higher scores indicate greater competence-based trust.

Immediately after exposure to the assigned health information condition.
Reciprocity or dependency dimension of trust in generative AI for health information
Aikaikkuna: Immediately after exposure to the assigned health information condition.

In Hunan and Tongzhou participants, assessed using the three-item Reciprocity or Dependency dimension of the Human-Generative AI Trust Scale. The items assess whether participants believe they can rely on generative AI, whether it can continue to support health decisions, and whether they refer to health information provided by generative AI. Items use a 5-point response scale and are averaged; higher scores indicate greater reciprocity-based trust.

Immediately after exposure to the assigned health information condition.
Psychological resilience
Aikaikkuna: Immediately after exposure to the assigned school-based health message.

In Tongzhou students and primary caregivers, assessed immediately after exposure using the 10-item Connor-Davidson Resilience Scale (CD-RISC-10). Each item is scored from 0 (not true at all) to 4 (true nearly all the time). The 10 item scores are summed to a total score ranging from 0 to 40; higher scores indicate greater psychological resilience. If the online platform stores responses as 1-5, scores will be recoded to 0-4 before summation.

Immediately after exposure to the assigned school-based health message.

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Sponsori

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Arvioitu)

Lauantai 28. marraskuuta 2026

Ensisijainen valmistuminen (Arvioitu)

Keskiviikko 28. marraskuuta 2029

Opintojen valmistuminen (Arvioitu)

Keskiviikko 28. marraskuuta 2029

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Tiistai 27. lokakuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Sunnuntai 8. marraskuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Tiistai 10. marraskuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Tiistai 10. marraskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Sunnuntai 8. marraskuuta 2026

Viimeksi vahvistettu

Torstai 1. lokakuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muut tutkimustunnusnumerot

  • E 26964
  • E 26964 (Muu tunniste: Ethics Committee of the Third Xiangya Hospital of Central South University)

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .